Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 239

Related Citations for PubMed (Select 22369141)

1.

Association between ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients.

Yang Y, Li W, Zhao J, Zhang H, Song X, Xiao B, Yang G, Jiang C, Zhang D, Yue W, Lv L.

Behav Brain Funct. 2012 Feb 28;8:11. doi: 10.1186/1744-9081-8-11.

2.

No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.

Lee HY, Kim DJ, Lee HJ, Choi JE, Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):276-80. doi: 10.1016/j.pnpbp.2008.11.013. Epub 2008 Dec 3.

PMID:
19059448
3.

Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population.

Ding S, Chen B, Zheng Y, Lu Q, Liu L, Zhuge QC.

BMC Psychiatry. 2013 Apr 5;13:107. doi: 10.1186/1471-244X-13-107.

4.

No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.

Zhang ZJ, Yao ZJ, Zhang XB, Chen JF, Sun J, Yao H, Hou G, Zhang XB.

Acta Pharmacol Sin. 2003 Mar;24(3):235-40.

5.

Are genes associated with energy metabolism important in asthma and BMI?

Szczepankiewicz A, Breborowicz A, Sobkowiak P, Popiel A.

J Asthma. 2009 Feb;46(1):53-8. doi: 10.1080/02770900802460514.

PMID:
19191138
6.

Association study of NRXN3 polymorphisms with schizophrenia and risperidone-induced bodyweight gain in Chinese Han population.

Hu X, Zhang J, Jin C, Mi W, Wang F, Ma W, Ma C, Yang Y, Li W, Zhang H, Du B, Li K, Liu C, Wang L, Lu T, Zhang H, Lv L, Zhang D, Yue W.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:197-202. doi: 10.1016/j.pnpbp.2012.12.007. Epub 2013 Jan 7.

PMID:
23306218
7.

Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.

Ujike H, Nomura A, Morita Y, Morio A, Okahisa Y, Kotaka T, Kodama M, Ishihara T, Kuroda S.

J Clin Psychiatry. 2008 Sep;69(9):1416-22.

PMID:
19193342
8.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
9.

Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.

Huo R, Tang K, Wei Z, Shen L, Xiong Y, Wu X, Niu J, Han X, Tian Z, Yang L, Feng G, He L, Qin S.

PLoS One. 2012;7(5):e34809. doi: 10.1371/journal.pone.0034809. Epub 2012 May 11.

10.

Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain.

Park YM, Choi JE, Kang SG, Koo SH, Kim L, Geum D, Lee HJ.

Hum Psychopharmacol. 2011 Jun-Jul;26(4-5):332-7. doi: 10.1002/hup.1210. Epub 2011 Jun 22.

PMID:
21695734
11.

Possible association of the pro-melanin-concentrating hormone gene with a greater body mass index as a side effect of the antipsychotic olanzapine.

Chagnon YC, Bureau A, Gendron D, Bouchard RH, Mérette C, Roy MA, Maziade M.

Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144B(8):1063-9.

PMID:
17541984
12.

Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment.

Tsai A, Liou YJ, Hong CJ, Wu CL, Tsai SJ, Bai YM.

Neuromolecular Med. 2011 Dec;13(4):328-33. doi: 10.1007/s12017-011-8159-5. Epub 2011 Sep 29.

PMID:
21956459
13.

Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients.

Bozina N, Kuzman MR, Medved V, Jovanovic N, Sertic J, Hotujac L.

J Psychiatr Res. 2008 Jan;42(2):89-97. Epub 2006 Nov 20.

PMID:
17113599
14.
15.

Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients.

Bozina N, Medved V, Kuzman MR, Sain I, Sertic J.

J Psychopharmacol. 2007 Sep;21(7):728-34. Epub 2006 Nov 8.

PMID:
17092963
16.

Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.

Houston JP, Kohler J, Bishop JR, Ellingrod VL, Ostbye KM, Zhao F, Conley RR, Poole Hoffmann V, Fijal BA.

J Clin Psychiatry. 2012 Aug;73(8):1077-86. doi: 10.4088/JCP.11m06916.

PMID:
22967772
17.

Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics.

Schuhmacher A, Becker T, Rujescu D, Quednow BB, Lennertz L, Wagner M, Benninghoff J, Rietschel M, Häfner H, Franke P, Wölwer W, Gaebel W, Maier W, Mössner R.

J Psychiatr Res. 2012 Aug;46(8):1073-80. doi: 10.1016/j.jpsychires.2012.04.021. Epub 2012 May 30.

PMID:
22655589
18.

Association of serotonin transporter gene (SLC6A4) polymorphisms with schizophrenia susceptibility and symptoms in a Chinese-Han population.

Li W, Yang Y, Lin J, Wang S, Zhao J, Yang G, Wang X, Ding M, Zhang H, Lv L.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:290-5. doi: 10.1016/j.pnpbp.2013.04.003. Epub 2013 Apr 11.

PMID:
23583772
19.

Association of estrogen receptor alpha gene polymorphism with age at onset, general psychopathology symptoms, and therapeutic effect of schizophrenia.

Wang S, Li W, Zhao J, Zhang H, Yang Y, Wang X, Yang G, Lv L.

Behav Brain Funct. 2013 Mar 15;9:12. doi: 10.1186/1744-9081-9-12.

20.

Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients.

Liu H, Wang C, Chen PH, Zhang BS, Zheng YL, Zhang CX, Meng HQ, Wang Y, Chen da C, Xiu MH, Kosten TR, Zhang XY.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):692-6. doi: 10.1016/j.pnpbp.2010.03.026. Epub 2010 Mar 25.

PMID:
20346996
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk